Jul 28, 2021 06:06 PM (GMT+8) · EqualOcean
Sinopharm announced that recently, Sinopharm group Zhijun (Shenzhen) Pharmaceutical Co., Ltd., the holding subsidiary of the company (hereinafter referred to as "Sinopharm Zhijun") and Shandong lono Pharmaceutical Co., Ltd. (hereinafter referred to as "Shandong lono") signed a contract on the transfer of drug listing license. Shandong lono will transfer to Sinopharm Zhijun based on the listing license of coxib tablets (30mg and 60mg) and provide technology transfer services.